-+ 0.00%
-+ 0.00%
-+ 0.00%

DIAMEDICA THERAPEUTICS: PREECLAMPSIA PHASE 2 TRIAL PRELIMINARY TOPLINE SAFETY, EFFICACY DATA FROM PART 1A OF STUDY EXPECTED IN Q2 2025

Reuters·03/17/2025 20:31:18

Please log in to view news